610
Views
11
CrossRef citations to date
0
Altmetric
Original

SIMVASTATIN RESTORES DOWN-REGULATED GATA-6 EXPRESSION IN PULMONARY HYPERTENSIVE RATS

, , , , &
Pages 411-426 | Received 04 Oct 2008, Accepted 09 Jan 2009, Published online: 18 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Laurence Dewachter, Céline Dewachter & Robert Naeije. (2010) New therapies for pulmonary arterial hypertension: an update on current bench to bedside translation. Expert Opinion on Investigational Drugs 19:4, pages 469-488.
Read now

Articles from other publishers (10)

Tetsuo Toyama, Tatiana V. Kudryashova, Asako Ichihara, Stefania Lenna, Agnieszka Looney, Yuanjun Shen, Lifeng Jiang, Leyla Teos, Theodore Avolio, Derek Lin, Ulas Kaplan, Grace Marden, Vrinda Dambal, Dmitry Goncharov, Horace Delisser, Robert Lafyatis, Francesca Seta, Elena A. Goncharova & Maria Trojanowska. (2023) GATA6 coordinates cross-talk between BMP10 and oxidative stress axis in pulmonary arterial hypertension. Scientific Reports 13:1.
Crossref
Kun‐Chen Lin, Jui‐Ning Yeh, Pei‐Lin Shao, John Y. Chiang, Pei‐Hsun Sung, Chi‐Ruei Huang, Yi‐Ling Chen, Hon‐Kan Yip & Jun Guo. (2023) Jagged/Notch proteins promote endothelial‐mesenchymal transition‐mediated pulmonary arterial hypertension via upregulation of the expression of GATAs . Journal of Cellular and Molecular Medicine 27:8, pages 1110-1130.
Crossref
Emmanuel Ato Williams, Vincenzo Russo, Sergio Ceraso, Dhiraj Gupta & Richard Barrett-Jolley. (2020) Anti-arrhythmic properties of non-antiarrhythmic medications. Pharmacological Research 156, pages 104762.
Crossref
Lei Wang, Ting Yang & Chen Wang. (2017) Are statins beneficial for the treatment of pulmonary hypertension?. Chronic Diseases and Translational Medicine 3:4, pages 213-220.
Crossref
Charbel A. Mouawad, May F. Mrad, Ghewa A. El‐Achkar, Ali Abdul‐Sater, Georges M. Nemer, Christophe Creminon, Sophie Lotersztajn & Aïda Habib. (2015) Statins Modulate Cyclooxygenase‐2 and Microsomal Prostaglandin E Synthase‐1 in Human Hepatic Myofibroblasts. Journal of Cellular Biochemistry 117:5, pages 1176-1186.
Crossref
Rama K. Krishna, Omar Issa, Debjit Saha, Francisco Yuri B. Macedo, Barbara Correal & Orlando Santana. (2015) Pleiotropic effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors in pulmonary diseases: A comprehensive review. Pulmonary Pharmacology & Therapeutics 30, pages 134-140.
Crossref
Angela Ghatnekar, Izabela Chrobak, Charlie Reese, Lukasz Stawski, Francesca Seta, Elaine Wirrig, Jesus Paez-Cortez, Margaret Markiewicz, Yoshihide Asano, Russell Harley, Richard Silver, Carol Feghali-Bostwick & Maria Trojanowska. (2013) Endothelial GATA-6 Deficiency Promotes Pulmonary Arterial Hypertension. The American Journal of Pathology 182:6, pages 2391-2406.
Crossref
J. Yao, M. Xiong, B. Tang, G. Chen, M. Liang, X. Ma, Z. Wang & Z. Wu. (2012) Simvastatin attenuates pulmonary vascular remodelling by down-regulating matrix metalloproteinase-1 and -9 expression in a carotid artery-jugular vein shunt pulmonary hypertension model in rats. European Journal of Cardio-Thoracic Surgery 42:5, pages e121-e127.
Crossref
Niki Katsiki, Anthony S Wierzbicki & Dimitri P Mikhailidis. (2011) Pulmonary arterial hypertension and statins: an update. Current Opinion in Cardiology 26:4, pages 322-326.
Crossref
Yun Hee LeeKwan Chang KimMin-Sun ChoYoung Mi Hong. (2011) Changes of Pulmonary Pathology and Gene Expressions After Simvastatin Treatment in the Monocrotaline-Induced Pulmonary Hypertension Rat Model. Korean Circulation Journal 41:9, pages 518.
Crossref